click below
click below
Normal Size Small Size show me how
NSCLC Stage IV
Mutation Treatment
| Treatment | Mutation |
|---|---|
| Alecitinib or Brigatinib or Lorlatinib or Ensartinib | ALK Rearrangement |
| Entrecitinib or Crizotinib or Reprotrectinib | ROS1 Rearrangement |
| Osimertinib or Afatinib | EGFR Mutation |
| Dabrafenib + Trametinib or Encorafinib + Binimetinib | BRAF V600E |
| Entrectinib or Larotrectinib or Repotrectinib | NTRK gene fusion |
| Capmatinib or Tepotinib | MET ex14 skipping mutation |
| Selpercatinib or Pralsetinib | RET Rearrangement |
| Pembrolizumab or Atezolizumab or Cemiplimab | PDL1 Expression ≥ 50% |
| Chemo + Checkpoint Inhibitor | No Mutation |